Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

Associations between serum 25OHD concentration and 2 SNPs, one in the vitamin D receptor (VDR) gene (rs4516035) and one in the group-specific component (GC) gene (rs12512631), were stronger during pregnancy in mothers whose children later developed type 1 diabetes than in mothers whose children did not (pinteraction = 0.03, 0.02, respectively).

Source: Abstract. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

474 mothers of type 1 diabetic children and 348 mothers of non-diabetic children were included in the study.

Source: Abstract.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Genetic determinants of serum 25-hydroxyvitamin D concentration during pregnancy and type 1 diabetes in the child

Study design awaiting verification · PLoS ONE · 2017

Original publication title

Genetic determinants of serum 25-hydroxyvitamin D concentration during pregnancy and type 1 diabetes in the child

Maija E. Miettinen; Melissa C. Smart; Leena Kinnunen; Valma Harjutsalo; Linnea Reinert-Hartwall; Irene Ylivinkka; Heljä-Marja Surcel; Christel Lamberg-Allardt; Graham A. Hitman; Jaakko Tuomilehto

© 2017 Miettinen et al

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

We show for the first time that there are differences in the strength of genetic determinants of serum 25OHD concentration during pregnancy between the mothers of type 1 diabetic and non-diabetic children. Our results emphasize that the in utero environment including maternal vitamin D metabolism should be important lines of investigation when searching for factors that lead to early programming of type 1 diabetes.

An extract from the source publication. Read it in context.

At a glance

Abstract: What objectives does the paper state?

The in utero environment plays an important role in shaping development and later life health of the fetus. It has been shown that maternal genetic factors in the metabolic pathway of vitamin D associate with type 1 diabetes in the child. In this study we analyzed the genetic determinants of serum 25-hydroxyvitamin D (25OHD) concentration during pregnancy in mothers whose children later developed type 1 diabetes and in control mothers.

Source: Objective

Abstract: Study design

474 mothers of type 1 diabetic children and 348 mothers of non-diabetic children were included in the study. We previously selected 7 single nucleotide polymorphisms (SNPs) in four genes in the metabolic pathway of vitamin D vitamin based on our previously published data demonstrating an association between genotype and serum 25OHD concentration. In this re-analysis, possible differences in strength in the association between the SNPs and serum 25OHD concentration in mothers of type 1 diabetic and non-diabetic children were investigated.

Serum 25OHD concentrations were previously shown to be similar between the mothers of type 1 diabetic and non-diabetic children and vitamin D deficiency prevalent in both groups.

Source: Study design

Abstract: Results

Associations between serum 25OHD concentration and 2 SNPs, one in the vitamin D receptor (VDR) gene (rs4516035) and one in the group-specific component (GC) gene (rs12512631), were stronger during pregnancy in mothers whose children later developed type 1 diabetes than in mothers whose children did not (pinteraction = 0.03, 0.02, respectively).

Source: Results

Abstract: Conclusions

We show for the first time that there are differences in the strength of genetic determinants of serum 25OHD concentration during pregnancy between the mothers of type 1 diabetic and non-diabetic children. Our results emphasize that the in utero environment including maternal vitamin D metabolism should be important lines of investigation when searching for factors that lead to early programming of type 1 diabetes.

Source: Conclusions
Authors’ abstract

Objective

The in utero environment plays an important role in shaping development and later life health of the fetus. It has been shown that maternal genetic factors in the metabolic pathway of vitamin D associate with type 1 diabetes in the child. In this study we analyzed the genetic determinants of serum 25-hydroxyvitamin D (25OHD) concentration during pregnancy in mothers whose children later developed type 1 diabetes and in control mothers.

Study design

474 mothers of type 1 diabetic children and 348 mothers of non-diabetic children were included in the study. We previously selected 7 single nucleotide polymorphisms (SNPs) in four genes in the metabolic pathway of vitamin D vitamin based on our previously published data demonstrating an association between genotype and serum 25OHD concentration. In this re-analysis, possible differences in strength in the association between the SNPs and serum 25OHD concentration in mothers of type 1 diabetic and non-diabetic children were investigated.

Serum 25OHD concentrations were previously shown to be similar between the mothers of type 1 diabetic and non-diabetic children and vitamin D deficiency prevalent in both groups.

Results

Associations between serum 25OHD concentration and 2 SNPs, one in the vitamin D receptor (VDR) gene (rs4516035) and one in the group-specific component (GC) gene (rs12512631), were stronger during pregnancy in mothers whose children later developed type 1 diabetes than in mothers whose children did not (pinteraction = 0.03, 0.02, respectively).

Conclusions

We show for the first time that there are differences in the strength of genetic determinants of serum 25OHD concentration during pregnancy between the mothers of type 1 diabetic and non-diabetic children. Our results emphasize that the in utero environment including maternal vitamin D metabolism should be important lines of investigation when searching for factors that lead to early programming of type 1 diabetes.

Publication and source details

Original title: Genetic determinants of serum 25-hydroxyvitamin D concentration during pregnancy and type 1 diabetes in the child

Maija E. Miettinen; Melissa C. Smart; Leena Kinnunen; Valma Harjutsalo; Linnea Reinert-Hartwall; Irene Ylivinkka; Heljä-Marja Surcel; Christel Lamberg-Allardt; Graham A. Hitman; Jaakko Tuomilehto

PLoS ONE · 2017

Competing Interests: The authors have declared that no competing interests exist.

* E-mail: maija.miettinen@thl.fi
© 2017 Miettinen et al2017Miettinen et alhttps://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.http://dx.doi.org/10.13039/501100005878Terveyden Tutkimuksen Toimikunta127219Tuomilehto Jaakko http://dx.doi.org/10.13039/501100001648European Foundation for the Study of DiabetesTuomilehto Jaakko http://dx.doi.org/10.13039/501100004191Novo NordiskLamberg-Allardt Christel Diabetes Research Foundation, Finlandhttp://orcid.org/0000-0002-5587-7227Miettinen Maija E. http://dx.doi.org/10.13039/501100004334Etelä-Pohjanmaan SairaanhoitopiiriEVO1107Tuomilehto Jaakko http://dx.doi.org/10.13039/501100003756Biomedicum Helsinki-säätiöhttp://orcid.org/0000-0002-5587-7227Miettinen Maija E. http://dx.doi.org/10.13039/100010125Jalmari ja Rauha Ahokkaan Säätiöhttp://orcid.org/0000-0002-5587-7227Miettinen Maija E. http://dx.doi.org/10.13039/100010114Yrjö Jahnssonin Säätiöhttp://orcid.org/0000-0002-5587-7227Miettinen Maija E. http://dx.doi.org/10.13039/501100004037Juho Vainion Säätiöhttp://orcid.org/0000-0002-5587-7227Miettinen Maija E. Suoma Loimaranta-Airila Fundhttp://orcid.org/0000-0002-5587-7227Miettinen Maija E. Onni and Hilja Tuovinen Foundationhttp://orcid.org/0000-0002-5587-7227Miettinen Maija E. http://dx.doi.org/10.13039/501100007083Orionin Tutkimussäätiöhttp://orcid.org/0000-0002-5587-7227Miettinen Maija E. Kyllikki and Uolevi Lehikoinen Foundationhttp://orcid.org/0000-0002-5587-7227Miettinen Maija E. Funded by The Finnish Academy (Grant No. 127219) (http://www.aka.fi/en/); The European Foundation for the Study of Diabetes (http://www.europeandiabetesfoundation.org/); Novo Nordisk Foundation (http://novonordiskfonden.dk/en); Diabetes Research Foundation (https://www.diabetestutkimus.fi/); South Ostrobothnia Central Hospital (EVO1107) (http://www.epshp.fi/en [link unavailable]); Biomedicum Helsinki Foundation (http://www.biomedicum.fi/index.php?page=112&lang=2 [link unavailable]); Jalmari and Rauha Ahokas Foundation (http://www.ahokkaansaatio.org/); Yrjö Jahnsson Foundation (http://www.yjs.fi/en/); Suoma Loimaranta-Airila Fund (http://www.european-funding-guide.eu/scholarship/14903-scholarship); Onni and Hilja Tuovinen Foundation (http://www.tuovisensaatio.fi/); Juho Vainio Foundation (http://juhovainionsaatio.fi/en/juho-vainio-foundation/); Orion Research Foundation (http://www.orion.fi/tutkimus/orionin-tutkimussaatio/); Kyllikki and Uolevi Lehikoinen Foundation (http://www.aurora-tietokanta.fi/grant/details/id/4096/refc/foundation/refa/details). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T22:26:47.145787+00:00

DOI: 10.1371/journal.pone.0184942 · PMC5627909